ESPERION THERAPEUTICS

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04 أغسطس 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Esperion Reports Second Quarter 2022 Financial Results and Provides Company Update

02 أغسطس 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Esperion Announces Establishment of Scientific Advisory Board to Support Pipeline and Life Cycle Management

25 يوليو 2022 15:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Report Second Quarter 2022 Financial Results August 2, 2022

12 يوليو 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Real World Data Analysis Reveals Nearly Half of All Adults at High Risk for ASCVD and Eligible for a Statin Were Not On Any Statin

03 يونيو 2022 12:30:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in the 2022 Jefferies Global Healthcare Conference

02 يونيو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Esperion Announces the Appointment of J. Martin Carroll to its Board of Directors

01 يونيو 2022 16:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces Five Abstracts Accepted for Presentation at the National Lipid Association Scientific Sessions

31 مايو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference

17 مايو 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Esperion Reports First Quarter 2022 Financial Results and Provides Company Update

03 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Esperion Announces Publication of CLEAR Harmony Open-Label Extension Study Data for Bempedoic Acid in the American Journal of Cardiology

02 مايو 2022 08:00:03 بحسب Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

29 أبريل 2022 17:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Upcoming Bank of America Securities 2022 Healthcare Conference

29 أبريل 2022 10:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces the Appointment of Stephen Rocamboli to its Board of Directors

28 أبريل 2022 16:00:00 بحسب Nasdaq GlobeNewswire

Esperion Supports Collaborative Study with an Integrated and Learning Health Care Delivery System in Northern California to Study the Effects of NEXLIZET® (bempedoic acid and ezetimibe) in Reducing LDL-Cholesterol Following a Recent Acute Coronary Syndrome Event

25 أبريل 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Esperion to Report First Quarter 2022 Financial Results May 3, 2022

19 أبريل 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Esperion Announces Publication of Phase 3 Data for Bempedoic Acid in the Journal of Clinical Lipidology

13 أبريل 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology’s 71st Annual Scientific Session & Expo

03 أبريل 2022 12:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Upcoming 21st Annual Needham Virtual Healthcare Conference

29 مارس 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Upcoming Virtual Cowen 42nd Annual Healthcare Conference

24 فبراير 2022 08:00:02 بحسب Nasdaq GlobeNewswire